Seylanmed
Berkeley, US · Founded 2016 · Delaware LLC
Founders & leadership
MD
Mark de SouzaManager
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 1 round · 2019
▶$1.2MraisedAug 2019 · 13 investors · BiotechnologyRule 506(b)
▶$1.2MraisedAug 2019 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark de SouzaExecutive Officer, Director
- Offering amount
- $2.1M
- Amount sold
- $1.2M
- First sale
- Jul 2019
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Seylanmed raised?
- Seylanmed has disclosed $1.2M raised across 1 round.
- Where is Seylanmed headquartered?
- Seylanmed is headquartered in Berkeley, US.